Gaush Meditech Ltd. provided group earnings guidance for the six months ended June 30, 2023. For the period, the company is expected that the Group will record a net profit of approximately RMB 104.9 million to RMB 115.9 million as compared to a net loss of approximately RMB 53.3 million for the six months ended June 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.04 HKD | -9.07% | -19.12% | -62.86% |
May. 30 | Gaush Meditech Ltd Declares Final Dividend for the Year Ended December 31, 2023 | CI |
May. 29 | Gaush Meditech Gets China Nod for Intraocular Lenses for Cataract Patients | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-62.86% | 293M | |
-9.39% | 8.78B | |
+1.58% | 1.45B | |
-8.30% | 1.35B | |
-4.89% | 1.17B | |
-28.86% | 746M | |
+1.67% | 462M | |
+1.47% | 432M | |
-35.28% | 286M | |
-0.08% | 215M |
- Stock Market
- Equities
- 2407 Stock
- News Gaush Meditech Ltd
- Gaush Meditech Ltd Provides Group Earnings Guidance for the Six Months Ended June 30, 2023